ID   STK39_RAT               Reviewed;         553 AA.
AC   O88506; O70541;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   02-OCT-2024, entry version 191.
DE   RecName: Full=STE20/SPS1-related proline-alanine-rich protein kinase;
DE            Short=Ste-20-related kinase;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9UEW8};
DE   AltName: Full=Pancreatic serine/threonine-protein kinase;
DE            Short=PS/TK;
DE            Short=PSTK1;
DE   AltName: Full=Serine/threonine-protein kinase 39;
GN   Name=Stk39; Synonyms=Pask {ECO:0000303|PubMed:10990492}, Spak;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9675032; DOI=10.1006/abbi.1998.0736;
RA   Ushiro H., Tsutsumi T., Suzuki K., Kayahara T., Nakano K.;
RT   "Molecular cloning and characterization of a novel Ste20-related protein
RT   kinase enriched in neurons and transporting epithelia.";
RL   Arch. Biochem. Biophys. 355:233-240(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Pancreas;
RX   PubMed=10990492; DOI=10.1177/002215540004801009;
RA   Miao N., Fung B., Sanchez R., Lydon J., Barker D., Pang K.;
RT   "Isolation and expression of PASK, a serine/threonine kinase, during rat
RT   embryonic development, with special emphasis on the pancreas.";
RL   J. Histochem. Cytochem. 48:1391-1400(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Insulinoma;
RX   PubMed=10980603; DOI=10.1038/sj.onc.1203784;
RA   Johnston A.M., Naselli G., Gonez L.J., Martin R.M., Harrison L.C.,
RA   de Aizpurua H.J.;
RT   "SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.";
RL   Oncogene 19:4290-4297(2000).
RN   [4]
RP   ACTIVITY REGULATION, PHOSPHORYLATION AT THR-240 AND SER-380, AND
RP   MUTAGENESIS OF ASP-212.
RX   PubMed=16083423; DOI=10.1042/bj20051180;
RA   Vitari A.C., Deak M., Morrice N.A., Alessi D.R.;
RT   "The WNK1 and WNK4 protein kinases that are mutated in Gordon's
RT   hypertension syndrome phosphorylate and activate SPAK and OSR1 protein
RT   kinases.";
RL   Biochem. J. 391:17-24(2005).
RN   [5]
RP   ACTIVITY REGULATION, PHOSPHORYLATION AT SER-380, AND MUTAGENESIS OF
RP   SER-380.
RX   PubMed=16263722; DOI=10.1074/jbc.m510042200;
RA   Moriguchi T., Urushiyama S., Hisamoto N., Iemura S., Uchida S., Natsume T.,
RA   Matsumoto K., Shibuya H.;
RT   "WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters
RT   via the STE20-related kinases, SPAK and OSR1.";
RL   J. Biol. Chem. 280:42685-42693(2005).
RN   [6]
RP   FUNCTION, ACTIVITY REGULATION, AND PHOSPHORYLATION AT SER-380.
RX   PubMed=22544747; DOI=10.1074/jbc.m111.319418;
RA   Inoue K., Furukawa T., Kumada T., Yamada J., Wang T., Inoue R., Fukuda A.;
RT   "Taurine inhibits K+-Cl- cotransporter KCC2 to regulate embryonic
RT   Cl- homeostasis via with-no-lysine (WNK) protein kinase signaling
RT   pathway.";
RL   J. Biol. Chem. 287:20839-20850(2012).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-363 AND SER-394, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Effector serine/threonine-protein kinase component of the
CC       WNK-SPAK/OSR1 kinase cascade, which is involved in various processes,
CC       such as ion transport, response to hypertonic stress and blood pressure
CC       (PubMed:22544747). Specifically recognizes and binds proteins with a
CC       RFXV motif (By similarity). Acts downstream of WNK kinases (WNK1, WNK2,
CC       WNK3 or WNK4): following activation by WNK kinases, catalyzes
CC       phosphorylation of ion cotransporters, such as SLC12A1/NKCC2,
CC       SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or SLC12A6/KCC3, regulating
CC       their activity (PubMed:22544747). Mediates regulatory volume increase
CC       in response to hyperosmotic stress by catalyzing phosphorylation of ion
CC       cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1 and SLC12A6/KCC3 downstream
CC       of WNK1 and WNK3 kinases (By similarity). Phosphorylation of Na-K-Cl
CC       cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation
CC       and ion influx; simultaneously, phosphorylation of K-Cl cotransporters
CC       SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion
CC       efflux (PubMed:22544747). Acts as a regulator of NaCl reabsorption in
CC       the distal nephron by mediating phosphorylation and activation of the
CC       thiazide-sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted
CC       tubule cells of kidney downstream of WNK4 (By similarity). Mediates the
CC       inhibition of SLC4A4, SLC26A6 as well as CFTR activities.
CC       Phosphorylates RELT (By similarity). {ECO:0000250|UniProtKB:Q9UEW8,
CC       ECO:0000250|UniProtKB:Q9Z1W9, ECO:0000269|PubMed:22544747}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9UEW8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9UEW8};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9Z1W9};
CC   -!- ACTIVITY REGULATION: Activated following phosphorylation at Thr-240 by
CC       WNK kinases (WNK1, WNK2, WNK3 or WNK4). {ECO:0000269|PubMed:16083423,
CC       ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:22544747}.
CC   -!- SUBUNIT: The phosphorylated form forms a complex with WNK2 (By
CC       similarity). Interacts with RELT (By similarity). Interacts with SORL1
CC       (via cytosolic C-terminus) (By similarity).
CC       {ECO:0000250|UniProtKB:Q9UEW8, ECO:0000250|UniProtKB:Q9Z1W9}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus {ECO:0000305}.
CC       Note=Nucleus when caspase-cleaved. {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis followed by pancreas,
CC       kidney, heart and brain (PubMed:10990492, PubMed:9675032). Not
CC       expressed in skeletal muscle, liver, lung and spleen (PubMed:10990492,
CC       PubMed:9675032). {ECO:0000269|PubMed:10990492,
CC       ECO:0000269|PubMed:9675032}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the early gut and pancreatic
CC       epithelium, at 15 dpc day localized to cells that will eventually
CC       become exocrine. Expressed in choroid plexus, developing myocardium,
CC       pancreatic epithelium and dorsal root ganglia.
CC       {ECO:0000269|PubMed:10990492}.
CC   -!- DOMAIN: PAPA box (proline-alanine repeats) may target the kinase to a
CC       specific subcellular location by facilitating interaction with
CC       intracellular proteins such as actin or actin-like proteins.
CC       {ECO:0000250|UniProtKB:Q9UEW8}.
CC   -!- PTM: Phosphorylation at Thr-240 by WNK kinases (WNK1, WNK2, WNK3 or
CC       WNK4) is required for activation (PubMed:16083423, PubMed:16263722).
CC       Autophosphorylation at Thr-240 positively regulates its activity (By
CC       similarity). Phosphorylated at Ser-318 by PRKCQ (By similarity).
CC       {ECO:0000250|UniProtKB:Q9UEW8, ECO:0000269|PubMed:16083423,
CC       ECO:0000269|PubMed:16263722}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D88190; BAA26000.1; -; mRNA.
DR   EMBL; AF068261; AAC23501.1; -; mRNA.
DR   EMBL; AF099990; AAC72239.1; -; mRNA.
DR   RefSeq; NP_062235.1; NM_019362.1.
DR   AlphaFoldDB; O88506; -.
DR   SMR; O88506; -.
DR   BioGRID; 248540; 3.
DR   ELM; O88506; -.
DR   IntAct; O88506; 1.
DR   STRING; 10116.ENSRNOP00000034162; -.
DR   BindingDB; O88506; -.
DR   ChEMBL; CHEMBL4105808; -.
DR   iPTMnet; O88506; -.
DR   PhosphoSitePlus; O88506; -.
DR   SwissPalm; O88506; -.
DR   jPOST; O88506; -.
DR   PaxDb; 10116-ENSRNOP00000034162; -.
DR   Ensembl; ENSRNOT00000098784.1; ENSRNOP00000089326.1; ENSRNOG00000024808.6.
DR   Ensembl; ENSRNOT00055039721; ENSRNOP00055032258; ENSRNOG00055023094.
DR   Ensembl; ENSRNOT00060004496; ENSRNOP00060003190; ENSRNOG00060002791.
DR   Ensembl; ENSRNOT00065027111; ENSRNOP00065021312; ENSRNOG00065016275.
DR   GeneID; 54348; -.
DR   KEGG; rno:54348; -.
DR   UCSC; RGD:621643; rat.
DR   AGR; RGD:621643; -.
DR   CTD; 27347; -.
DR   RGD; 621643; Stk39.
DR   eggNOG; KOG0582; Eukaryota.
DR   GeneTree; ENSGT00940000154621; -.
DR   HOGENOM; CLU_000288_111_1_1; -.
DR   InParanoid; O88506; -.
DR   OMA; CKFIQKA; -.
DR   OrthoDB; 152877at2759; -.
DR   PhylomeDB; O88506; -.
DR   TreeFam; TF105339; -.
DR   BRENDA; 2.7.11.1; 5301.
DR   PRO; PR:O88506; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000024808; Expressed in testis and 19 other cell types or tissues.
DR   ExpressionAtlas; O88506; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0005938; C:cell cortex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006884; P:cell volume homeostasis; ISO:RGD.
DR   GO; GO:0071474; P:cellular hyperosmotic response; ISO:RGD.
DR   GO; GO:0071476; P:cellular hypotonic response; ISO:RGD.
DR   GO; GO:1990869; P:cellular response to chemokine; ISO:RGD.
DR   GO; GO:0035865; P:cellular response to potassium ion; ISO:RGD.
DR   GO; GO:0038146; P:chemokine (C-X-C motif) ligand 12 signaling pathway; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0030644; P:intracellular chloride ion homeostasis; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0042116; P:macrophage activation; ISO:RGD.
DR   GO; GO:0036438; P:maintenance of lens transparency; ISO:RGD.
DR   GO; GO:0050801; P:monoatomic ion homeostasis; ISO:RGD.
DR   GO; GO:0090188; P:negative regulation of pancreatic juice secretion; ISO:RGD.
DR   GO; GO:1901380; P:negative regulation of potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0043268; P:positive regulation of potassium ion transport; IMP:RGD.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; ISO:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0070294; P:renal sodium ion absorption; ISO:RGD.
DR   GO; GO:1904044; P:response to aldosterone; ISO:RGD.
DR   GO; GO:0002021; P:response to dietary excess; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   CDD; cd06610; STKc_OSR1_SPAK; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050629; STE20/SPS1-PAK.
DR   PANTHER; PTHR48012:SF14; STE20_SPS1-RELATED PROLINE-ALANINE-RICH PROTEIN KINASE; 1.
DR   PANTHER; PTHR48012; STERILE20-LIKE KINASE, ISOFORM B-RELATED; 1.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..553
FT                   /note="STE20/SPS1-related proline-alanine-rich protein
FT                   kinase"
FT                   /id="PRO_0000086724"
FT   DOMAIN          72..346
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          319..544
FT                   /note="Interaction with RELT"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1W9"
FT   REGION          370..431
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           369..375
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           396..400
FT                   /note="Caspase cleavage related site"
FT   COMPBIAS        33..55
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        400..422
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        201
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         78..86
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         101
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         240
FT                   /note="Phosphothreonine; by WNK1"
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   MOD_RES         244
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1W9"
FT   MOD_RES         318
FT                   /note="Phosphoserine; by PKC/PRKCQ"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UEW8"
FT   MOD_RES         358
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UEW8"
FT   MOD_RES         363
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UEW8"
FT   MOD_RES         380
FT                   /note="Phosphoserine; by WNK1"
FT                   /evidence="ECO:0000269|PubMed:16083423,
FT                   ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:22544747"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         402
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1W9"
FT   MUTAGEN         212
FT                   /note="D->A: Abolished serine/threonine-protein kinase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   MUTAGEN         380
FT                   /note="S->A: Decreased phosphorylation by WNK1."
FT                   /evidence="ECO:0000269|PubMed:16263722"
FT   CONFLICT        11
FT                   /note="V -> I (in Ref. 2; AAC23501)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        253
FT                   /note="M -> I (in Ref. 2; AAC23501)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403
FT                   /note="E -> Q (in Ref. 2; AAC23501)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   553 AA;  60051 MW;  8BC1458AEA6F90C8 CRC64;
     MAEPSGSPVH VQLPQQAAPV TAAAAAPAAA TSAPAPAPAP AAPAAPAPAP AAAPAPAPAA
     QAVGWPICRD AYELQEVIGS GATAVVQAAL CKPRQERVAI KRINLEKCQT SMDELLKEIQ
     AMSQCSHPNV VTYYTSFVVK DELWLVMKLL SGGSMLDIIK YIVNRGEHKN GVLEEAIIAT
     ILKEVLEGLD YLHRNGQIHR DLKAGNILLG EDGSVQIADF GVSAFLATGG DVTRNKVRKT
     FVGTPCWMAP EVMEQVRGYD FKADMWSFGI TAIELATGAA PYHKYPPMKV LMLTLQNDPP
     TLETGVEDKE MMKKYGKSFR KLLSLCLQKD PSKRPTAAEL LKCKFFQKAK NREYLIEKLL
     TRTPDIAQRA KKVRRVPGSS GHLHKTEDGD WEWSDDEMDE KSEEGKAAAS QEKSRRVKEE
     NPEISVNAGG IPEQIQSLSV HDSQGQPNAN EDYREGPCAV NLVLRLRNSR KELNDIRFEF
     TPGRDTADGV SQELFSAGLV DGHDVVIVAA NLQKIVDDPK ALKTLTFKLA SGCDGAEIPD
     EVKLIGFAQL SVS
//
